Try Claude
Academic ResearchSearch papers, authors, citations
AI Tools for Research Scientists
AI tools that help research scientists search literature, access datasets, find grants, discover collaborators, and communicate findings across disciplines.
Get started for free
Works in Chat, Cowork and Code
He & He (Nature Cell Biology, 2022)
892 citations · off-target profiling in primary T cells using GUIDE-seq
Anzalone et al. (Nature, 2023)
641 citations · base editing comparison — off-target rates vs. Cas9 nuclease
Weng et al. (Nature Biotechnology, 2023)
487 citations · high-fidelity Cas9 variants in HSCs
Key Gap
Limited longitudinal data on persistent off-target edits in engrafted primary cells
Literature search and systematic review
Search millions of peer-reviewed papers, filter by date, citation count, and author to conduct rigorous literature reviews faster. Identify key papers, research gaps, and leading research groups in any field.
Search for all papers on RNA m6A methylation and its role in cancer progression from 2020 onwards. Sort by citation count and identify the top 5 most influential.
Found 847 papers from 2020–2024. Top 5 by citations: (1) He & He (Nature Cell Biology, 2022) — 892 citations, m6A reader YTHDF2 in glioblastoma. (2) Liu et al. (Cell, 2021) — 743 citations, METTL3 as oncogene in AML. (3) Weng et al. (Nature Medicine, 2022) — 671 citations, m6A modification and immune evasion. Key gap identified: limited mechanistic studies on m6A erasers in solid tumors.
ToolRouter search_papers
He & He (Nature Cell Biology, 2022)
892 citations · YTHDF2 reader role in glioblastoma progression
Liu et al. (Cell, 2021)
743 citations · METTL3 as oncogene in AML
Weng et al. (Nature Medicine, 2022)
671 citations · m6A modification and immune evasion
Research Gap
Limited mechanistic studies on m6A erasers in solid tumors
Grant and funding discovery
Find relevant funding opportunities from NIH, NSF, ERC, Wellcome Trust, and national funding bodies. Filter by research area, career stage, and funding type to identify grants you are eligible to apply for.
Find NIH and NSF grants for early-career researchers (within 5 years of PhD) working on computational neuroscience and brain-computer interfaces. Include award amounts and deadlines.
Found 8 matching opportunities. Top picks: NIH BRAIN Initiative K99/R00 Pathway Award (up to $249K/year, rolling deadline). NSF CAREER Award ($500K over 5 years, next deadline February). NIH R01 first-time investigator pool (10% set-aside for new investigators, upcoming deadline October 5). Chan Zuckerberg Initiative Neurodegeneration Challenge (up to $1M, letters of intent due November 15).
ToolRouter search_grants
NIH BRAIN Initiative K99/R00
Up to $249K/year · rolling deadline · early investigator pathway
NSF CAREER Award
$500K over 5 years · next deadline February · foundational research
NIH R01 First-Time Investigator Pool
10% set-aside for new investigators · upcoming deadline October 5
Chan Zuckerberg Initiative
Up to $1M · letters of intent due November 15 · neurodegeneration challenge
Chemical compound and reagent lookup
Look up chemical properties, safety data, GHS classifications, and hazard information for research reagents. Access comprehensive compound data to support lab safety compliance and protocol development.
I need GHS safety data and key physical properties for three reagents: ethidium bromide, acrylamide, and beta-mercaptoethanol for our lab safety documentation.
Ethidium bromide: GHS Acute Toxicity Cat 4, Mutagenic Cat 2 — requires designated waste disposal. Acrylamide: GHS Carcinogen Cat 1B, Reproductive Toxin Cat 1B — must use gloves and ventilation; handle as powder in fume hood. Beta-mercaptoethanol: GHS Acute Toxicity Cat 3 (inhalation), Skin Corrosion Cat 1 — handle only in fume hood; vapor is highly toxic.
ToolRouter lookup_compound
Ethidium Bromide
GHS Acute Toxicity Cat 4 · Mutagenic Cat 2 — designated waste disposal required
Acrylamide
GHS Carcinogen Cat 1B · Reproductive Toxin Cat 1B — fume hood required; handle powder carefully
Beta-Mercaptoethanol
GHS Acute Toxicity Cat 3 (inhalation) · Skin Corrosion Cat 1 — fume hood only; vapor highly toxic
Clinical trial and translational research tracking
Search ClinicalTrials.gov for active studies in your research area to understand the translational landscape, identify collaborators, and contextualize basic science findings.
Find all active Phase I and Phase II clinical trials testing CAR-T cell therapies for solid tumors — not hematological malignancies. Include lead institutions.
Found 67 active trials. Phase I: 41 trials (mostly dose escalation at academic centers). Phase II: 26 trials. Top lead institutions: MD Anderson Cancer Center (12 trials), Memorial Sloan Kettering (9 trials), Universitätsklinikum Würzburg (7 trials). Most common targets: HER2 (18 trials), mesothelin (14 trials), GD2 (9 trials).
ToolRouter search_trials
Nct numberLead institutionTarget
NCT05318768MD AndersonHER2
NCT05402020Memorial Sloan KetteringMesothelin
NCT05289934MD AndersonGD2 (sarcoma)
NCT05487041Universitätsklinikum WürzburgEGFR
67 active trials · MD Anderson leads with 12 trials
Global R&D landscape and policy research
Access country-level data on research investment, publication output, and innovation metrics to contextualize grant applications, support international collaboration proposals, and benchmark research programs.
Pull R&D expenditure as a percentage of GDP for the US, EU, China, South Korea, and Japan for the past 10 years. Which countries are increasing investment fastest?
R&D/GDP trends 2013–2023: South Korea leads at 4.9% (up from 4.1%). Israel 5.4% (highest globally, stable). US 3.4% (gradual increase from 2.7%). China 2.6% (fastest absolute increase — up from 1.9%). EU average 2.2% (slow growth). Key insight for your proposal: China's R&D investment growth is the primary driver of the "competitive research landscape" narrative.
ToolRouter get_indicator
South Korea
United States
China
Drug and compound mechanism research
Research FDA drug labeling data, mechanism of action, and clinical evidence for compounds relevant to your research area — useful for pharmacology studies and translational research context.
Look up the FDA approved indications, mechanism of action, and key clinical trial data for pembrolizumab as context for my PD-1/PD-L1 basic research paper.
Pembrolizumab (Keytruda): Humanized anti-PD-1 IgG4 mAb. Mechanism: blocks PD-1/PD-L1 interaction, restoring T cell cytotoxic function against tumor cells. FDA approved for 20+ indications including NSCLC, melanoma, HNSCC, and tumor-agnostic TMB-high. Key trials: KEYNOTE-001 (Phase I, established dose), KEYNOTE-024 (first-line NSCLC PD-L1 ≥50%, landmark OS benefit). 2023 global sales $25.0B.
ToolRouter lookup_drug
Drug Class
Humanized anti-PD-1 IgG4 monoclonal antibody
Mechanism
Blocks PD-1/PD-L1 interaction · restores T cell cytotoxic function against tumor cells
FDA Approvals
20+ indications: NSCLC, melanoma, HNSCC, TMB-high tumor-agnostic
Key Trials
KEYNOTE-001 (Phase I, dose) · KEYNOTE-024 (first-line NSCLC, PD-L1 ≥50%)
2023 Global Sales
$25.0B
Ready-to-use prompts
Systematic literature review
Search peer-reviewed literature on the gut microbiome and its role in modulating response to immune checkpoint inhibitors in cancer patients. Find meta-analyses and mechanistic studies from 2019–2024.
NIH grant search
Find current NIH R01 and R21 funding opportunities relevant to single-cell transcriptomics and spatial genomics methods development. Include deadlines and expected award amounts.
Reagent safety lookup
Look up GHS hazard classifications, safety handling requirements, and disposal procedures for: 4% paraformaldehyde, RNase A, DAPI stain, and propidium iodide.
Clinical trial landscape
Find active Phase II and Phase III trials testing mRNA-based therapeutics (not vaccines) for any indication. Include trial sponsor, enrollment size, and primary endpoint.
R&D investment benchmarking
Pull World Bank data on R&D expenditure as % of GDP for the top 15 research-intensive countries over the past 15 years. Which countries show the strongest investment growth?
Drug mechanism research
Look up the FDA label, mechanism of action, and major clinical trial data for semaglutide as context for a metabolic disease research paper.
Citation impact analysis
Search for the 20 most cited papers on CRISPR base editing published since 2016. Include author names, journals, and citation counts to map the leading research groups.
Research scientist job market
Find research scientist and principal scientist positions in computational biology and bioinformatics at biotech companies and research institutes in the Boston and San Francisco Bay Area.
Tools to power your best work
Country DataFacts for any country, instantly
World Economy16000+ World Bank indicators & data
Drug InformationDrug info: recalls & side effects
Job SearchJobs & salary data worldwide
Chemistry LookupCompounds, elements, and safety
Clinical TrialsClinical trials & drug safety data
Grants FinderFind grants, funding fits, and precedent
165+ tools.
One conversation.
Everything research scientists need from AI, connected to the assistant you already use. No extra apps, no switching tabs.
Grant application preparation
Compile the literature, data, and competitive landscape needed to write a strong grant application.
New research area onboarding
Rapidly get up to speed on a new research area — key papers, leading groups, active clinical work, and available reagents.
Translational research context building
Connect basic science findings to clinical relevance by mapping the trial landscape and approved drugs in your research area.
Frequently Asked Questions
How many papers does the academic research tool cover?
Academic Research searches millions of peer-reviewed papers across major scientific databases. Coverage includes life sciences, physical sciences, engineering, social sciences, and humanities — with citation counts, author affiliations, and abstracts.
Can I find grants for specific career stages like early investigator awards?
Grants Finder supports filtering by career stage, funding type, and research area. Early-career specific programs like NIH K99/R00, NSF CAREER, and equivalent international awards are indexed alongside standard project grants.
Is the chemistry lookup tool useful for lab safety documentation?
Chemistry Lookup retrieves GHS hazard classifications, signal words, precautionary statements, and physical properties for chemical compounds. This is useful for generating SDS summaries, training materials, and waste disposal documentation.
How current is the clinical trials database?
Clinical Trials queries ClinicalTrials.gov in real time. All trial records including current status, enrollment figures, primary endpoints, and lead investigators are current as of the day of the search.
Can these tools help me write the significance section of a grant?
Deep Research and World Economy can provide global R&D investment statistics, disease burden data, and competitive landscape summaries useful for framing significance. Academic Research helps identify the specific gaps your work addresses.
Give your AI superpowers.
Get started for free
Works in Chat, Cowork and Code